Top Markets
#1 TENDIES TENDIES +60.89%
#2 Threshold Network Threshold Network +54.06%
#3 Cash Cat Cash Cat +21.98%
#4 OSK OSK +16.53%
#5 Kinetiq Kinetiq +16.42%
#6 Mubarak Mubarak +13.34%
#7 Maple Finance Maple Finance +13.30%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Magma Finance Magma Finance +12.08%
#10 Kite Kite +11.50%
Coin of the day
TENDIES TENDIES
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Classifica tra le azioni #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Prezzo delle azioni
$1.33
Ultima sincronizzazione: 2026-09-01
Capitalizzazione di mercato
$246.43M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-23.56%
Paese
US
Scambia Neumora Therapeutics, Inc. Common Stock (NMRA)

Categoria

Healthcare
Storico del prezzo dell'azione per Neumora Therapeutics, Inc. Common Stock (NMRA)
Prezzo di chiusura più alto: $1.36 il 2026-09-01

Prezzo di chiusura più basso: $12.50 il 2023-09-01
Storico del prezzo dell'azione di Neumora Therapeutics, Inc. Common Stock dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $554.82 38.36%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.67%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.77 515.03%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.39 8.87%
CH